The PD-1/PD-L1 inhibitor alone was able to increase the cytotoxic activity of NK-92 cells, showing that the PD-1/PD-L1 axis contributes to immunosuppression between NK cells and cancer cells (Fig. 1d, e). The gene discussed is CD274; the disease is cancer.